Tag
CYB003
- Psychedelic drug developer Cybin secures major financing deal
- Billionaire Steve Cohen's Point 72 hedge fund takes 8.1% stake in Cybin
- Cybin reaches end of psilocybin analogue clinical trial for depression
- Cybin administers psychedelic analogue to patients with major depression
- Cybin receives Schedule I DEA license for CYB003 trial